Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
American Journal of Perinatology · 01.03.2024 · 41 (04) · 505-510
DOI: 10.1055/a-1709-5036 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.03.2024. Verfasst von Secil Ercin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, Koc University Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hyperbilirubinemia, Neonatal, Blood Group Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
ABO blood group (ABO) incompatibility is a common cause of neonatal indirect hyperbilirubinemia. The direct antiglobulin test (DAT) can identify infants developing hemolytic disease. This study aims to evaluate the significance of DAT positivity among neonates with ABO incompatibility. Study Design This retrospective study included 820 neonates with blood group A or B who were born to blood group O mothers. The study group consisted of neonates (n = 79) who had positive DAT, and the control group consisted of infants (n = 741) who had negative DAT. Demographic and clinical data of the neonates regarding jaundice were collected and compared statistically.
Results
The bilirubin level at 24 hours of life (study group: 8 ± 2.6 mg/dL, control group: 6 ± 2.2 mg/dL, p < 0.001) and the highest bilirubin level (study group: 12.7 ± 3.6 mg/dL, control group: 10.4 ± 4.2 mg/dL, p < 0.001) were higher in infants with positive DAT. A total of 37 (46.8%) infants in the study group and 83 (11.2%) infants in the control group received phototherapy (PT) in the nursery (p < 0.001). In neonates with positive DAT, direct bilirubin level, duration of hospitalization, and PT in the nursery were higher (p = 0.002,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, Koc University Hospital, Istanbul, Turkey.
- Department of Pediatrics, Koc University Hospital, Istanbul, Turkey.
- Division of Neonatology, Department of Pediatrics, Koc University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Secil Ercin, Yesim Coskun, Kalender Kayas, Nazan Kavas, Tugba Gursoy
Zitieren
APA
Ercin, S., Coskun, Y., Kayas, K., Kavas, N., & Gursoy, T. (2024). Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?. American Journal of Perinatology, 41(04), 505-510. https://doi.org/10.1055/a-1709-5036
Vancouver
Ercin S, Coskun Y, Kayas K, Kavas N, Gursoy T. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?. American Journal of Perinatology. 2024;41(04):505-510. doi:10.1055/a-1709-5036
BibTeX
@article{Ercin2024,
author = {Ercin, Secil and Coskun, Yesim and Kayas, Kalender and Kavas, Nazan and Gursoy, Tugba},
title = {Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {04},
pages = {505--510},
doi = {10.1055/a-1709-5036}
}
EUVIMED